SE9904389L - IGF-1 receptorinteragerande proteiner (IIP:er), gener som kodar för dessa och användningar därav - Google Patents

IGF-1 receptorinteragerande proteiner (IIP:er), gener som kodar för dessa och användningar därav

Info

Publication number
SE9904389L
SE9904389L SE9904389A SE9904389A SE9904389L SE 9904389 L SE9904389 L SE 9904389L SE 9904389 A SE9904389 A SE 9904389A SE 9904389 A SE9904389 A SE 9904389A SE 9904389 L SE9904389 L SE 9904389L
Authority
SE
Sweden
Prior art keywords
igf
iips
genes coding
interacting proteins
receptor interacting
Prior art date
Application number
SE9904389A
Other languages
Unknown language ( )
English (en)
Other versions
SE523013C2 (sv
SE9904389D0 (sv
Inventor
Tanja Ligensa
Ralf Schumacher
Michael Weidner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE9904389D0 publication Critical patent/SE9904389D0/sv
Publication of SE9904389L publication Critical patent/SE9904389L/sv
Publication of SE523013C2 publication Critical patent/SE523013C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE9904389A 1998-12-03 1999-12-02 Nukleinsyra (IIP-10) som kodar för en IGF-1-receptorbindande polypeptid samt användning av nukleinsyran eller polypeptiden i en metod för detektion av proliferationspotentialen hos en cancercell eller för att identifiera ämnen som modulerar interaktionen mellan IIP-10 och IGF-1R SE523013C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98122992A EP1006184A1 (en) 1998-12-03 1998-12-03 IGF-1 receptor interacting proteins (IIPs) genes coding therefor and uses thereof

Publications (3)

Publication Number Publication Date
SE9904389D0 SE9904389D0 (sv) 1999-12-02
SE9904389L true SE9904389L (sv) 2000-06-04
SE523013C2 SE523013C2 (sv) 2004-03-23

Family

ID=8233086

Family Applications (2)

Application Number Title Priority Date Filing Date
SE9904389A SE523013C2 (sv) 1998-12-03 1999-12-02 Nukleinsyra (IIP-10) som kodar för en IGF-1-receptorbindande polypeptid samt användning av nukleinsyran eller polypeptiden i en metod för detektion av proliferationspotentialen hos en cancercell eller för att identifiera ämnen som modulerar interaktionen mellan IIP-10 och IGF-1R
SE0301757A SE526919C8 (sv) 1998-12-03 2003-06-18 Nukleinsyra (IIP) som kodar för en IGF-1 receptorbindande polypeptid samt användning därav i en metod för detektion av proliferationspotentialen hos en cancercell eller för att identifiera föreningar som inhiberar interaktionen mellan IIP-1 och IGF-1R

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE0301757A SE526919C8 (sv) 1998-12-03 2003-06-18 Nukleinsyra (IIP) som kodar för en IGF-1 receptorbindande polypeptid samt användning därav i en metod för detektion av proliferationspotentialen hos en cancercell eller för att identifiera föreningar som inhiberar interaktionen mellan IIP-1 och IGF-1R

Country Status (13)

Country Link
US (6) US6368826B1 (sv)
EP (1) EP1006184A1 (sv)
JP (3) JP3294575B2 (sv)
AU (1) AU728102B2 (sv)
BE (1) BE1013527A3 (sv)
CA (1) CA2289914C (sv)
CH (1) CH694204A5 (sv)
DE (3) DE19958198B4 (sv)
FR (1) FR2788783B1 (sv)
GB (1) GB2347930B (sv)
IT (1) IT1314250B1 (sv)
NL (1) NL1013748C2 (sv)
SE (2) SE523013C2 (sv)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197582B1 (en) * 1998-03-18 2001-03-06 The Trustees Of Columbia University In The City Of New York Development of human monoclonal antibodies and uses thereof
US7060802B1 (en) * 2000-09-18 2006-06-13 The Trustees Of Columbia University In The City Of New York Tumor-associated marker
US7638605B2 (en) * 2003-05-01 2009-12-29 ImClone, LLC Fully human antibodies directed against the human insulin-like growth factor-1 receptor
MY146381A (en) * 2004-12-22 2012-08-15 Amgen Inc Compositions and methods relating relating to anti-igf-1 receptor antibodies
CA2612449A1 (en) 2005-06-17 2006-12-28 Imclone Systems Incorporated Receptor antagonists for treatment of metastatic bone cancer
DK1926996T3 (da) * 2005-09-20 2012-01-23 Osi Pharmaceuticals Llc Biologiske markører, som er prædiktive for anti-cancer-reaktion på insulinlignende vækstfaktor-1-receptorkinasehæmmere
CN101484587B (zh) * 2006-02-03 2014-02-12 英克隆有限责任公司 Igf-ir拮抗剂作为辅药用于***癌的治疗
US20070245980A1 (en) * 2006-03-27 2007-10-25 Phillips Terry G Water heating systems and methods
WO2008065636A2 (en) * 2006-12-01 2008-06-05 University College York - National University Of Ireland, Cork Treatment of disease by modulating cf5 protein
WO2008079849A2 (en) * 2006-12-22 2008-07-03 Genentech, Inc. Antibodies to insulin-like growth factor receptor
ES2707551T3 (es) * 2007-03-02 2019-04-04 Amgen Inc Métodos y composiciones para tratar enfermedades tumorales
MX2010002249A (es) * 2007-08-31 2010-03-17 Amgen Inc Formulacion de proteina de estado solido.
US8383114B2 (en) * 2007-09-27 2013-02-26 Amgen Inc. Pharmaceutical formulations
EP3381445B1 (en) 2007-11-15 2023-10-25 Amgen Inc. Aqueous formulation of antibody stablised by antioxidants for parenteral administration
US20100316639A1 (en) 2009-06-16 2010-12-16 Genentech, Inc. Biomarkers for igf-1r inhibitor therapy
WO2011050333A1 (en) 2009-10-23 2011-04-28 Amgen Inc. Vial adapter and system
ME02206B (me) * 2010-05-27 2016-02-20 Centocor Ortho Biotech Inc Receptor insulinu-sličnog faktora rasta 1 vezujući peptidi
ES2545411T5 (es) 2010-06-07 2024-04-05 Amgen Inc Dispositivo de administración de fármaco
JP2014510265A (ja) 2011-02-02 2014-04-24 アムジェン インコーポレイテッド Ｉｇｆ−１ｒの阻害に関する方法および組成物
MX341790B (es) 2011-03-31 2016-09-02 Amgen Inc Adaptador de viales y sistema.
AU2012245231B2 (en) 2011-04-20 2016-10-13 Amgen Inc. Autoinjector apparatus
CN103930142B (zh) 2011-10-14 2016-12-14 安姆根有限公司 注射器和装配方法
AU2012335541B2 (en) 2011-11-11 2017-07-06 Duke University Combination drug therapy for the treatment of solid tumors
US8980259B2 (en) 2012-07-20 2015-03-17 Novartis Ag Combination therapy
SI3081249T1 (sl) 2012-11-21 2021-03-31 Amgen Inc. Naprava za dajanje zdravila
CA2904725C (en) 2013-03-15 2022-04-12 Amgen Inc. Drug cassette, autoinjector, and autoinjector system
JP6768501B2 (ja) 2013-03-15 2020-10-14 アムゲン・インコーポレーテッド 薬物カセット、自動注入機、および自動注入機システム
WO2014149357A1 (en) 2013-03-22 2014-09-25 Amgen Inc. Injector and method of assembly
PL3060275T3 (pl) 2013-10-24 2019-12-31 Amgen Inc. Wstrzykiwacz i sposób montażu
EP3060281B1 (en) 2013-10-24 2019-01-30 Amgen Inc. Drug delivery system with temperature-sensitive control
WO2015119906A1 (en) 2014-02-05 2015-08-13 Amgen Inc. Drug delivery system with electromagnetic field generator
AU2015256082C1 (en) 2014-05-07 2020-09-10 Amgen Inc. Autoinjector with shock reducing elements
CN112237662B (zh) 2014-06-03 2022-10-21 安姆根有限公司 药物递送***和使用方法
AU2015332557B2 (en) 2014-10-14 2020-05-14 Amgen Inc. Drug injection device with visual and audio indicators
JP6716566B2 (ja) 2014-12-19 2020-07-01 アムジエン・インコーポレーテツド 近接センサ付き薬物送達装置
ES2785311T3 (es) 2014-12-19 2020-10-06 Amgen Inc Dispositivo de administración de fármacos con botón móvil o campo de interfaz de usuario
CA2976935C (en) 2015-02-17 2020-03-10 Amgen Inc. Drug delivery device with vacuum assisted securement and/or feedback
ES2905870T3 (es) 2015-02-27 2022-04-12 Amgen Inc Dispositivo de suministro de fármacos que tiene un mecanismo de protección de aguja con un umbral de resistencia ajustable al movimiento de la protección de aguja
WO2017039786A1 (en) 2015-09-02 2017-03-09 Amgen Inc. Syringe assembly adapter for a syringe
WO2017100501A1 (en) 2015-12-09 2017-06-15 Amgen Inc. Auto-injector with signaling cap
WO2017120178A1 (en) 2016-01-06 2017-07-13 Amgen Inc. Auto-injector with signaling electronics
WO2017129763A1 (en) 2016-01-28 2017-08-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of signet ring cell gastric cancer
EP3429663B1 (en) 2016-03-15 2020-07-15 Amgen Inc. Reducing probability of glass breakage in drug delivery devices
WO2017189089A1 (en) 2016-04-29 2017-11-02 Amgen Inc. Drug delivery device with messaging label
WO2017192287A1 (en) 2016-05-02 2017-11-09 Amgen Inc. Syringe adapter and guide for filling an on-body injector
MX2018013616A (es) 2016-05-13 2019-02-21 Amgen Inc Montaje de cubierta protectora de vial.
US11238150B2 (en) 2016-05-16 2022-02-01 Amgen Inc. Data encryption in medical devices with limited computational capability
WO2017209899A1 (en) 2016-06-03 2017-12-07 Amgen Inc. Impact testing apparatuses and methods for drug delivery devices
WO2018004842A1 (en) 2016-07-01 2018-01-04 Amgen Inc. Drug delivery device having minimized risk of component fracture upon impact events
US20190328965A1 (en) 2016-08-17 2019-10-31 Amgen Inc. Drug delivery device with placement detection
EP3532127A1 (en) 2016-10-25 2019-09-04 Amgen Inc. On-body injector
AU2018210301A1 (en) 2017-01-17 2019-08-01 Amgen Inc. Injection devices and related methods of use and assembly
MX2019009755A (es) 2017-02-17 2019-10-07 Amgen Inc Mecanismo de insercion para dispositivo de suministro de farmacos.
WO2018151890A1 (en) 2017-02-17 2018-08-23 Amgen Inc. Drug delivery device with sterile fluid flowpath and related method of assembly
EP3592403A1 (en) 2017-03-06 2020-01-15 Amgen Inc. Drug delivery device with activation prevention feature
IL268478B2 (en) 2017-03-07 2023-10-01 Amgen Inc Inserting a needle using super pressure
IL268386B2 (en) 2017-03-09 2023-11-01 Amgen Inc Insertion mechanism for a drug delivery device
EP4241807A3 (en) 2017-03-28 2023-10-11 Amgen Inc. Plunger rod and syringe assembly system and method
AU2018282077B2 (en) 2017-06-08 2023-11-23 Amgen Inc. Torque driven drug delivery device
AU2018280054B2 (en) 2017-06-08 2023-07-13 Amgen Inc. Syringe assembly for a drug delivery device and method of assembly
US11541183B2 (en) 2017-06-22 2023-01-03 Amgen Inc. Device activation impact/shock reduction
JP7475860B2 (ja) 2017-06-23 2024-04-30 アムジエン・インコーポレーテツド スイッチアセンブリにより起動されるキャップを含む電子薬物送達デバイス
ES2972207T3 (es) 2017-07-14 2024-06-11 Amgen Inc Sistema de inserción-retracción de agujas con sistema de resorte de torsión doble
MA49626A (fr) 2017-07-21 2020-05-27 Amgen Inc Élément d'étanchéité perméable aux gaz pour récipient à médicament et procédés d'assemblage
EP4085942A1 (en) 2017-07-25 2022-11-09 Amgen Inc. Drug delivery device with gear module and related method of assembly
EP3658206A1 (en) 2017-07-25 2020-06-03 Amgen Inc. Drug delivery device with container access system and related method of assembly
EP3664863A2 (en) 2017-08-09 2020-06-17 Amgen Inc. Hydraulic-pneumatic pressurized chamber drug delivery system
EP3668567A1 (en) 2017-08-18 2020-06-24 Amgen Inc. Wearable injector with sterile adhesive patch
US11103636B2 (en) 2017-08-22 2021-08-31 Amgen Inc. Needle insertion mechanism for drug delivery device
WO2019070472A1 (en) 2017-10-04 2019-04-11 Amgen Inc. FLOW ADAPTER FOR MEDICATION DELIVERY DEVICE
IL272636B1 (en) 2017-10-06 2024-06-01 Amgen Inc Drug delivery device with combination assembly and related assembly method
WO2019074579A1 (en) 2017-10-09 2019-04-18 Amgen Inc. DRUG DELIVERY DEVICE COMPRISING A DRIVE ASSEMBLY AND ASSEMBLY METHOD THEREOF
EP3703778A1 (en) 2017-11-03 2020-09-09 Amgen Inc. System and approaches for sterilizing a drug delivery device
WO2019089178A1 (en) 2017-11-06 2019-05-09 Amgen Inc. Drug delivery device with placement and flow sensing
WO2019090303A1 (en) 2017-11-06 2019-05-09 Amgen Inc. Fill-finish assemblies and related methods
SG11202002966QA (en) 2017-11-10 2020-05-28 Amgen Inc Plungers for drug delivery devices
SG11202002772VA (en) 2017-11-16 2020-04-29 Amgen Inc Autoinjector with stall and end point detection
IL273638B1 (en) 2017-11-16 2024-06-01 Amgen Inc Door lock mechanism for drug delivery device
US10835685B2 (en) 2018-05-30 2020-11-17 Amgen Inc. Thermal spring release mechanism for a drug delivery device
US11083840B2 (en) 2018-06-01 2021-08-10 Amgen Inc. Modular fluid path assemblies for drug delivery devices
WO2020023336A1 (en) 2018-07-24 2020-01-30 Amgen Inc. Hybrid drug delivery devices with grip portion
WO2020023220A1 (en) 2018-07-24 2020-01-30 Amgen Inc. Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation
US12042645B2 (en) 2018-07-24 2024-07-23 Amgen Inc. Delivery devices for administering drugs
MX2021000749A (es) 2018-07-24 2021-03-29 Amgen Inc Dispositivos de suministro para administrar farmacos.
WO2020028009A1 (en) 2018-07-31 2020-02-06 Amgen Inc. Fluid path assembly for a drug delivery device
US20210346601A1 (en) 2018-09-24 2021-11-11 Amgen Inc. Interventional dosing systems and methods
CA3110371A1 (en) 2018-09-28 2020-04-02 Amgen Inc. Muscle wire escapement activation assembly for a drug delivery device
EP3860685A1 (en) 2018-10-02 2021-08-11 Amgen Inc. Injection systems for drug delivery with internal force transmission
EP3860686A1 (en) 2018-10-05 2021-08-11 Amgen Inc. Drug delivery device having dose indicator
CA3109988A1 (en) 2018-10-15 2020-04-23 Amgen Inc. Platform assembly process for drug delivery device
MA53912A (fr) 2018-10-15 2022-01-19 Amgen Inc Dispositif d'administration de médicament comprenant un mécanisme d'amortissement
TWI831847B (zh) 2018-11-01 2024-02-11 美商安進公司 部分針頭縮回之藥物遞送裝置及其操作方法
CA3113076A1 (en) 2018-11-01 2020-05-07 Amgen Inc. Drug delivery devices with partial drug delivery member retraction
US11213620B2 (en) 2018-11-01 2022-01-04 Amgen Inc. Drug delivery devices with partial drug delivery member retraction
MX2021012557A (es) 2019-04-24 2021-11-12 Amgen Inc Conjuntos y metodos de verificacion de esterilizacion de jeringuillas.
MX2022002149A (es) 2019-08-23 2022-03-17 Amgen Inc Dispositivo de suministro de farmacos con componentes de acoplamiento de capuchon de aguja configurable y metodos relacionados.
US20240208680A1 (en) 2021-05-21 2024-06-27 Amgen Inc. Method of optimizing a filling recipe for a drug container

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2915082A (en) 1956-12-03 1959-12-01 Evart V Shaw Automobile beverage container assembly
CA1219824A (en) 1981-04-17 1987-03-31 David C. Ward Modified nucleotides and methods of preparing and using same
JPH0743376B2 (ja) 1983-05-31 1995-05-15 オルジェニックス リミテッド 核酸配列の検定方法及び分子遺伝子プローブ
DE3431536A1 (de) 1984-08-28 1986-03-13 Boehringer Mannheim Gmbh, 6800 Mannheim Derivatisierte nucleinsaeure-sequenz, verfahren zu deren herstellung sowie deren verwendung zum nachweis von nucleinsaeuren
ES8706823A1 (es) 1985-03-28 1987-06-16 Cetus Corp Un procedimiento para detectar la presencia o ausencia de al menos una secuencia especifica de acidos nucleicos en una muestra
DE3813278A1 (de) 1988-01-12 1989-07-20 Boehringer Mannheim Gmbh Verfahren zum nachweis von nukleinsaeuren
EP0679716A4 (en) * 1993-11-12 1999-06-09 Kenichi Matsubara GENE SIGNATURE.
US5650415A (en) * 1995-06-07 1997-07-22 Sugen, Inc. Quinoline compounds
EP0876483A1 (en) * 1996-01-26 1998-11-11 HSC Research and Development Limited Partnership Nucleic acids and proteins related to alzheimer's disease, and uses therefor
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
WO2000060080A2 (en) * 1999-04-05 2000-10-12 Incyte Pharmaceuticals, Inc. Molecules of the immune system
AU5047800A (en) * 1999-05-28 2000-12-18 Ludwig Institute For Cancer Research Breast, gastric and prostate cancer associated antigens and uses therefor

Also Published As

Publication number Publication date
GB2347930B (en) 2001-01-31
JP3294575B2 (ja) 2002-06-24
US20060040358A1 (en) 2006-02-23
AU6305999A (en) 2000-09-07
US6913883B2 (en) 2005-07-05
US6368826B1 (en) 2002-04-09
SE0301757D0 (sv) 2003-06-18
SE526919C2 (sv) 2005-11-15
GB2347930A (en) 2000-09-20
US7329734B2 (en) 2008-02-12
US20050019832A1 (en) 2005-01-27
US20020042389A1 (en) 2002-04-11
NL1013748C2 (nl) 2001-12-28
ITMI992519A0 (it) 1999-12-02
US7202058B2 (en) 2007-04-10
BE1013527A3 (fr) 2002-03-05
JP2001218599A (ja) 2001-08-14
DE19958198A1 (de) 2000-06-08
DE19964268B4 (de) 2004-01-29
AU728102B2 (en) 2001-01-04
DE19964269B4 (de) 2005-10-27
JP2000166555A (ja) 2000-06-20
CA2289914A1 (en) 2000-06-03
SE523013C2 (sv) 2004-03-23
US20040225114A1 (en) 2004-11-11
IT1314250B1 (it) 2002-12-06
NL1013748A1 (nl) 2000-06-06
IE991020A1 (en) 2000-06-28
CH694204A5 (de) 2004-09-15
SE9904389D0 (sv) 1999-12-02
SE526919C8 (sv) 2005-12-14
EP1006184A1 (en) 2000-06-07
ITMI992519A1 (it) 2001-06-02
FR2788783A1 (fr) 2000-07-28
FR2788783B1 (fr) 2004-04-02
JP4638549B2 (ja) 2011-02-23
DE19958198B4 (de) 2007-03-08
JP2010000082A (ja) 2010-01-07
US20090018312A1 (en) 2009-01-15
CA2289914C (en) 2008-01-22
GB9928450D0 (en) 2000-01-26

Similar Documents

Publication Publication Date Title
SE0301757D0 (sv) IGF-1 receptorinteragerande proteiner (IIP:er), gener som kodar för dessa och användningar därav
EP1009814A4 (en) TYROSINE KINASE RECEPTOR, KDR
CY1106815T1 (el) Αλληλουχιες νουκλεινικου οξεος του αδενοσχετιζομενου ιου του οροτυπου 1 και φορεις και κυτταρα ξενιστες περιεχοντας αυτες
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
WO2002028901A3 (en) Seven-transmembrane (7tm) receptors and uses thereof
CA2284859A1 (en) Nucleic acid molecule for a human skeletal muscle-specific receptor
EP2014770A3 (en) WNT-1 Iinduced secreted polypeptide WISP-2
WO2002000722A3 (en) Human calcium channels (48000; 52920) and uses thereof
ATE119545T1 (de) Felincalicivirus-capsid-protein und nukleotidsequenz.
NZ334839A (en) Polynucleotide molecules encoding neospora proteins and uses thereof
CA2253006A1 (en) .beta.-carotene hydroxylase gene
WO2001049714A3 (en) Nope polypeptides, encoding nucleic acids and methods of use
ATE304553T1 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
ATE463510T1 (de) Polypeptide und für diese kodierende gene
DE69936513D1 (de) Menschliche p51-gene und deren genprodukte
AU4945001A (en) Angiogenesis associated proteins, and nucleic acids encoding the same
WO2001068857A3 (en) 18615 and 48003, human ion channels and uses therefor
DE69900109D1 (de) Tgf-beta rii rezeptor nukleinsäuresequenz, dadurch kodiertes peptid, und verwendungen davon
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
WO2003020912A3 (en) Novel clark protein and nucleic acid molecules and uses therefor
EE200100234A (et) PRV-1-geen ja selle kasutamine
MXPA01011563A (es) Una novedosa proteina 5 relacionada al factro-h y anticuerpos relacionados.
WO2001062926A3 (en) 44576, a novel g-protein coupled receptor and uses therefor
WO2002006325A3 (en) 32529, a human guanine nucleotide exchange factor family member and uses thereof
EP1247864A3 (en) 58297, an amino acid transporter and uses therefor

Legal Events

Date Code Title Description
NUG Patent has lapsed